Centauri Software’s The OsteoReport: Osteoreport.com

The Osteo Report®
This software provides the DXA center user with a variety of essential bone density test reporting functions. The program can auto-interpret the patient's bone density test results for the hip, spine, and wrist according to the guidelines set by the user.  Another feature is Oracle®, an accessory that provides the user with a number of effective ways to use the information stored in The Osteo Report® for practice management, marketing, and scientific research. Custom queries can be quickly generated by Oracle® even by those new to searching databases. Any combination of patient demographic, risk factor, or BMD data can be searched with Oracle®.

Doctor's Guide to the Internet - Osteoporosis

Hologic Corporation: Hologic.com

A leading maker of central and peripheral bone densitometers.

International Society for Clinical Densitometry Web Site: ISCD.org

The International Society for Clinical Densitometry (ISCD) is the premier, industry neutral, nonprofit organization providing a central educational resource for various scientific disciplines with an interest in bone mass measurement.  The mission of the ISCD is to enhance knowledge and quality of densitometry among healthcare professionals, provide continuing education courses for clinicians and technologists, increase patient awareness and access to densitometry, and support clinical and scientific advances in the field.

ISCD Calculator for determining the Least Significant Change in a DXA Bone Density Test result: http://www.iscd.org/Visitors/links/calc.cfm

Cool stuff from ISCD for calculating the Least Significant Change and the time needed before a repeat DXA test should be performed.

Eli Lilly’s Patient Assistance Program: lillyanswers.com

Lilly Answers will bring immediate help to seniors without prescription drug coverage whose incomes are too high to qualify for Medicaid, but limited enough that paying cash for necessary medicines presents a significant financial barrier. Building on our long tradition of patient assistance, Lilly Answers will ensure that seniors have complete access to the Lilly products, information and services they need.  Under Lilly Answers, eligible seniors will have access to Lilly's portfolio of products for illnesses such as osteoporosis (Evista and Forteo), diabetes, depression and schizophrenia-chronic diseases that afflict nearly 18 million or one in every two seniors.

Eli Lilly’s official EVISTA® web site: Evista.com

Evista (raloxifene HCl) is a prescription medication approved for the prevention and treatment of osteoporosis in women after menopause. This section will help you understand more about EVISTA.

Eli Lilly’s Forteo Web Site: Forteo.com

Eli Lilly’s site is intended for patients and health care professionals who have been educated on the full product profile of FORTEO^® (teriparatide [rDNA origin] injection).

GE Medical Systems

A leading maker of central and peripheral bone densitometers.

Kyphoplasty Treatment for Acute Vertebral Fractures: Kyphon.com

Kyphoplasty is a new technique doctors are using in the treatment of spine fractures.  The treatment is a very effective way to quickly stabilize the broken bone and usually results in a marked reduction of pain.  It is a minimally invasive type of surgery performed through two small holes made over the fractured vertebra in the back.  A small balloon tipped plastic tube is placed into the broken bone and inflated.  Cement is then injected into the space made by the ballon that glues the fractured bone back together.  This treatment stabilizes the fracture resulting in reduction of pain. 

Merck’s Fosamax Web Site: Fosamax.com

FOSAMAX is for the treatment and prevention of osteoporosis (thinning of bone) in postmenopausal women. It reduces the chance of fractures, including those of the spine and hip.

Proctor and Gamble Pharmaceutical’s Actonel Web Site: Actonel.com

Actonel is indicated to prevent and treat osteoporosis in postmenopausal women and to prevent and treat osteoporosis due to glucocorticoids.

National Osteoporosis Foundation: NOF.org

The National Osteoporosis Foundation (NOF) is the leading nonprofit, voluntary health organization dedicated to promoting lifelong bone health in order to reduce the widespread prevalence of osteoporosis and associated fractures, while working to find a cure for the disease through programs of research, education and advocacy.

National Osteoporosis Society: NOS.org.uk

The NOS offers support to people in the United Kingdom with osteoporosis, their families and care givers through a range of information booklets, a national telephone helpline and a network of regional support groups. Increasing numbers of people develop osteoporosis and more people need our help every year.

National Institutes of Health Osteoporosis and Related Disease Resource Center: Osteo.org

The National Resource Center, a part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), provides patients, health professionals, and the public with an important link to resources and information on metabolic bone diseases, including osteoporosis, Paget's disease of the bone, osteogenesis imperfecta, and hyperparathyroidism.

Novartis’ Miacalcin Nasal Spray Web Site: Miacalcin.com

MIACALCIN Nasal Spray is a prescription medication recommended for the treatment of postmenopausal osteoporosis in women more than 5 years after menopause who have low bone mass, and who can't or won't take estrogens, or for whom estrogens are not an option.

Osteoporosis Society of Canada: Osteoporosis.ca/english/home/

The mission of the Osteoporosis Society of Canada is to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis.

Osteogenesis Imperfecta Foundation: OIF.org

Osteogenesis imperfecta (OI) is a genetic disorder in which the bones are fragile due to defective collagen. Collagen is an important protein found in the body's connective tissues, such as bone and cartilage. In people with OI, either the quantity or the quality of collagen is abnormal, resulting in bones that are less dense and break easily.

Roche Pharmaceutical’s Bonvia Web Site: RocheUsa.com/products/boniva/

Boniva is indicated for the treatment and prevention of osteoporosis in postmenopausal women. The recommended dose of Boniva is 2.5 mg (oral tablet) once daily.